Inamed Says Board Approves Allergan Offer

Inamed Corp. said its board had unanimously approved Botox maker Allergan Inc.’s $3.2-billion offer in a deal that would allow Allergan to expand its wrinkle-treatment product line.

Inamed, which also makes breast implants, said it hadn’t signed the agreement, which wouldn’t be finalized until Irvine-based Allergan said it was satisfied with its investigation of Inamed’s wrinkle smoother Juvederm.

Santa Barbara-based Inamed this week agreed to pay a $90-million breakup fee to end its $2.83-billion merger deal with Medicis Pharmaceutical Corp.